Prostate Cancer: Science and Clinical Practice

by Jack H. Mydlo MD, FACS (Editor), Ciril J. Godec (Editor)

Overview

Prostate Cancer, Science and Clinical Practice, Second Edition, continues to be an important translational reference that bridges the gap between science and clinical medicine. It reviews the biological processes that can be implicated in the disease, reviews current treatments, highlights the pitfalls where relevant, and examines the scientific developments that might result in future treatments.

Key chapters from the previous edition have been updated, and a plethora of new chapters describe new concepts of prostate cancer biology and newly developed therapeutics. Each chapter has been written by internationally recognized specialists on prostate cancer epidemiology, genetic susceptibility, cancer metastases, prostate physiology, proteomics, new therapeutics, and clinical trials.

• Presents a comprehensive, translational source for all aspects of prostate cancer in one reference work
• Provides a common language for cancer researchers, oncologists, and urologists to discuss prostate tumors and how prostate cancer metastases affects other major organ systems
• Offers insights to research clinicians, giving them a key understanding the molecular basis of prostate cancer
• Offers insights to cancer researchers into how clinical observations and practices can feed back into the research cycle and, therefore, can contribute to the development of more targeted genomic and proteomic assays

Product Details

ISBN-13:	9780128005927
Publisher:	Elsevier Science
Publication date:	09/29/2015
Sold by:	Barnes & Noble
Format:	eBook
Pages:	672
File size:	45 MB
Note:	This product may take a few minutes to download.

About the Author

Jack H. Mydlo, MD, FACS, is Professor and Chair of Urology at Temple University School of Medicine. A native of Brooklyn, he went to SUNY Buffalo for undergraduate work and then received his MD degree from SUNY Downstate Medical School in 1981. Following his urology residency at Montefiore Hospital/Einstein College of Medicine in the Bronx, he completed a three-year fellowship at Memorial Sloan Kettering in 1989. He returned to SUNY Downstate Medical School as an Assistant Professor of Urology and progressed to an Associate Professor of Urology. He accepted the position of Professor and Chair of Urology at Temple University Hospital in 2000. He is also the residency program director for the Urology Department.

Dr. Mydlo has published over 100 peer-reviewed articles, several textbook chapters, and has edited two urological textbooks in renal and prostate cancer. His interests include urologic trauma, urologic oncology, and erectile dysfunction. He has lectured in numerous cities over the United States and Europe. He is a member of the American Urological Association as well as a member of the AUA Judicial and Ethics Committee, The Mid-Atlantic Section of the AUA, The Philadelphia Urologic Society, and a fellow of the American College of Surgeons.

Dr. Ciril J. Godec completed Medical School in 1963 in Ljubljana, Slovenia. In 1969, he passed the Urology Board in Ljubljana. In 1972, Dr. Godec completed his Ph.D. on Rehabilitation of the Neurogenic Bladder under the mentorship of Prof. Dimitrievich from Baylor University. In 1972, as a Fulbright Scholar, he researched bladder dysfunction under Dr. Saul Boyarsky, Professor and Chair of Urology at Washington University in St. Louis, Missouri. After delivering a lecture at the University of Minnesota, Dr. Godec was invited to stay and do research work at St. Paul-Ramsey Hospital. In 1979, he passed his Urology Board in the United States, and shortly thereafter, became the Co-Chief of Urology at Hennepin County Medical Center in Minneapolis.

In 1983, Dr. Godec relocated to New York City to become Chair of Urology and local residency coordinator at Long Island College Hospital. In 2000, Dr. Godec became Professor of Urology at Downstate Medical School in Brooklyn, New York. In 2013, he was invited to become the Urology Residency Director and Associate Chief of the Division of Urology at Maimonides Medical Center, the position he still occupies today.

During his career, Dr. Godec has been involved as co-investigator in four NIH grants. He has published 105 articles, five book chapters, 41 abstracts, and numerous presentations at national and international meetings, as well as 60 articles in non-medical newspapers. He has served as a reviewer for Urology and was on editorial boards of two medical journals. In 2003, Drs. Mydlo and Godec edited the first edition of Prostate Cancer.

Dr. Godec has lectured and performed surgery at many medical schools around the world to demonstrate his technique of open bloodless surgery for prostate cancer. At Downstate Medical School in the Department of Urology, he was selected as the Teacher of the Year twice, in 2006 and 2011. In 2015, while at Maimonides Medical Center, he was selected again as the Teacher of the Year.

In 2009, Dr. Godec received a lifetime achievement award from Cobble Hill Medical Center in Brooklyn, where he served as a Board Member until recently. He has been listed in Best Doctors in the US and in New York City, and is also a member of many medical professional societies, including AMA and AUA.

Table of Contents

Part I: Etiology, Pathology and Tumor Biology

Part II: Genetic Susceptibility and Hereditary Predisposition, Screening and Counseling

Part III: Epidemiology

Part IV: Prevention of Prostate Cancer

Part V:  Conservative Management

Part VI:  Surgery

Part VII:  Radiation Therapy

Part VIII:  Clinical dilemmas

Part IX:  Advanced prostate cancer

Part X: Cryoablation, HIFU and Focal Therapy

Part XI: Cryoablation, HIFU and Focal Therapy

Part XII: Govermental Policies

Part XIII:  New Horizons for Prostate Cancer

What People are Saying About This

From the Publisher

A translational reference on prostate cancer that bridges the gap from basic science to clinical analysis and new therapeutic approaches

Editorial Reviews

"...of great value to students, residents, researchers, scientists, and practicing urologists...a necessary reference for anyone interested in prostate cancer. Its strength lies in its ability to cover all relevant aspects in one book. Score: 99 - 5 Stars" —Doody's

From the Publisher

Reviewer: Mohamed T Ismail, MD (VA Medical Center Wilmington)
Description: In this second edition of a comprehensive book on prostate cancer, experts review various aspects of the field. The previous edition was published in 2003.
Purpose: The authors successfully present a balanced review of prostate cancer. The field of urology has changed much since 2003, making this update necessary.
Audience: This would be of great value to students, residents, researchers, scientists, and practicing urologists. The authors include a variety of talented and innovative urologists representing some of the top researchers in prostate cancer.
Features: The book is divided into 12 parts, with the first five covering the etiology, pathology, tumor biology, genetic susceptibility, epidemiology, and prevention of prostate cancer. Subsequently, the book covers management of localized disease, clinical dilemmas, namely, PSA recurrence following surgery or radiation, management of locally advanced disease, advanced prostate cancer, cryoablation, HIFY and focal therapies. The last two parts cover governmental policies and new horizons.
Assessment: This is a necessary reference for anyone interested in prostate cancer. Its strength lies in its ability to cover all relevant aspects in one book. Since the last edition, much has changed, including PSA screening, robotic surgery, management of advanced disease, and the economics of healthcare.

Doody's Review Service